Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-005376
Filing Date
2023-02-28
Accepted
2023-02-28 08:37:32
Documents
104
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mrsn-20221231.htm   iXBRL 10-K 2382768
2 EX-4.3 exhibit43-descriptionofreg.htm EX-4.3 22676
3 EX-10.18 exhibit1018-mersanaatsacol.htm EX-10.18 634303
4 EX-10.21 exhibit1021-secondamendmen.htm EX-10.21 36537
5 EX-10.22 exhibit1022-thirdamendment.htm EX-10.22 63661
6 EX-10.40 exhibit1040mersana-espp201.htm EX-10.40 72077
7 EX-10.42 exhibit1042-amendedandrest.htm EX-10.42 46362
8 EX-21.1 exhibit21110kfy2022q4.htm EX-21.1 3532
9 EX-23.1 exhibit23110kfy2022q4.htm EX-23.1 6754
10 EX-31.1 exhibit31110kfy2022q4.htm EX-31.1 10175
11 EX-31.2 exhibit31210kfy2022q4.htm EX-31.2 10171
12 EX-32.1 exhibit32110kfy2022q4.htm EX-32.1 6272
13 EX-97 exhibit97-clawbackpolicy.htm EX-97 8773
19 mrsn-20221231_g1.jpg GRAPHIC 139934
20 mrsn-20221231_g2.jpg GRAPHIC 279935
  Complete submission text file 0001628280-23-005376.txt   11776005

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrsn-20221231.xsd EX-101.SCH 66829
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrsn-20221231_cal.xml EX-101.CAL 80264
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrsn-20221231_def.xml EX-101.DEF 318121
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrsn-20221231_lab.xml EX-101.LAB 789905
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrsn-20221231_pre.xml EX-101.PRE 528603
98 EXTRACTED XBRL INSTANCE DOCUMENT mrsn-20221231_htm.xml XML 1452558
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38129 | Film No.: 23678623
SIC: 2834 Pharmaceutical Preparations